Drug delivery to the intestinal lymph by oral formulations

References

• Ahn H, Park JH. 2016. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 20(1):1–6.
   PubMedGoogle Scholar
• Aji Alex MR, Chacko AJ, Jose S, Souto EB. 2011. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci. 42(1–2):11–18.
   PubMed Web of Science ®Google Scholar
• Attili-Qadri S, Karra N, Nemirovski A, Schwob O, Talmon Y, Nassar T, Benita S. 2013. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc Natl Acad Sci USA. 110(43):17498–17503.
   PubMed Web of Science ®Google Scholar
• Baek JS, Cho CW. 2017. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Eur J Pharm Biopharm. 117:132–140.
   PubMed Web of Science ®Google Scholar
• Bagchus WM, Hust R, Maris F, Schnabel PG, Houwing NS. 2003. Important effect of food on the bioavailability of oral testosterone undecanoate. Pharmacotherapy. 23(3):319–325.
   PubMed Web of Science ®Google Scholar
• Banno F, Doisaki S, Shimizu N, Fujimoto K. 2002. Lymphatic absorption of docosahexaenoic acid given as monoglyceride, diglyceride, triglyceride, and ethyl ester in rats. J Nutr Sci Vitaminol. 48(1):30–35.
   PubMed Web of Science ®Google Scholar
• Beg S, Kazmi I, Afzal O, Alfawaz Altamimi AS, Al-Abbasi FA, Almalki WH, Alghamdi S, Alrobaian M, Alharbi KS, Alshammari MS, et al. 2021. Implications of phospholipid-based nanomixed micelles of olmesartan medoxomil with enhanced lymphatic drug targeting ability and systemic bioavailability. J Drug Deliv Sci Technol. 62:102273.
   Web of Science ®Google Scholar
• Beloqui A, Solinís MÁ, Gascón AR, Del Pozo-Rodríguez A, Des Rieux A, Préat V. 2013. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Control Release. 166(2):115–123.
   PubMed Web of Science ®Google Scholar
• Bergstedt SE, Hayashi H, Kritchevsky D, Tso P. 1990. A comparison of absorption of glycerol tristearate and glycerol trioleate by rat small intestine. Am J Physiol – Gastrointest Liver Physiol. 259(3):G386–G393.
   Web of Science ®Google Scholar
• Bernier-Latmani J, Petrova TV. 2017. Intestinal lymphatic vasculature: structure, mechanisms and functions. Nat Rev Gastroenterol Hepatol. 14(9):510–526.
   PubMed Web of Science ®Google Scholar
• Bhutiani N, Samykutty A, McMasters KM, Egilmez NK, McNally LR. 2019. In vivo tracking of orally-administered particles within the gastrointestinal tract of murine models using multispectral optoacoustic tomography. Photoacoustics. 13:46–52.
   PubMed Web of Science ®Google Scholar
• Blanchet B, Hulin A, Ghaleh B, Giraudier S, Jouault H, Astier A. 2006. Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibition. Fundam Clin Pharmacol. 20(2):137–144.
   PubMed Web of Science ®Google Scholar
• Bloom B, Chaikoff IL. Reinhardt   1951. Intestinal lymph as pathway for transport of absorbed fatty acids of different chain lengths. Am J Physiol. 166(2):451–455.
   PubMed Web of Science ®Google Scholar
• Bora CR, Prabhu RH, Patravale VB. 2017. Lymphatic delivery: concept, challenges and applications… – Google Scholar. Ind Dru. 54(08):5–22.
   Google Scholar
• Burns CP, Halabi S, Clamon G, Kaplan E, Hohl RJ, Atkins JN, Schwartz MA, Wagner BA, Paskett E. 2004. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: a cancer and leukemia group B study. Cancer. 101(2):370–378.
   PubMed Web of Science ®Google Scholar
• Cai Q, Deng X, Li Z, An D, Shen T, Zhong M. 2016. Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats. Drug Deliv. 23(1):147–153.
   PubMed Web of Science ®Google Scholar
• Cai S, Yang Q, Bagby TR, Forrest ML. 2011. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv Drug Deliv Rev. 63(10–11):901–908.
   PubMed Web of Science ®Google Scholar
• Caliph S, (Fried) Faassen W, Vogel G, Porter C. 2009. Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues. CDD. 6(4):359–366.
   PubMedGoogle Scholar
• Caliph SM, Cao E, Bulitta JB, Hu L, Han S, Porter CJH, Trevaskis NL. 2013. The impact of lymphatic transport on the systemic disposition of lipophilic drugs. J Pharm Sci. 102(7):2395–2408.
   PubMed Web of Science ®Google Scholar
• Caliph SM, Charman WN, Porter CJH. 2000. Effect of short‐, medium‐, and long‐chain fatty acid‐based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph‐cannulated and non‐cannulated rats. J Pharm Sci. 89(8):1073–1084.
   PubMed Web of Science ®Google Scholar
• Cesta MF. 2006. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol. 34(5):599–608.
   PubMed Web of Science ®Google Scholar
• Chai GH, Hu FQ, Sun J, Du YZ, You J, Yuan H. 2014. Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayer. Mol Pharm. 11(10):3716–3726.
   PubMed Web of Science ®Google Scholar
• Chance B, Glickson JD. 2006. WO2006073419A2 – Lipoprotein nanoplatforms – Google Patents. https://patents.google.com/patent/WO2006073419A2/en.
   Google Scholar
• Chaturvedi S, Garg A, Verma A. 2020. Nano lipid based carriers for lymphatic voyage of anti-cancer drugs: an insight into the in-vitro, ex-vivo, in-situ and in-vivo study models. J Drug Deliv Sci Technol. 59:101899.
   Web of Science ®Google Scholar
• Chen MCM, Wang JL, Tzen JTC. 2005. Elevating bioavailability of cyclosporine A via encapsulation in artificial oil bodies stabilized by caleosin. Biotechnol Prog. 21(4):1297–1301.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Park JW, Yoon IS, Kim DD. 2014. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomedicine. 9(1):495–504.
   PubMed Web of Science ®Google Scholar
• Cho HY, Choi JH, Oh IJ, Lee YB. 2015. Self-emulsifying drug delivery system for enhancing bioavailability and lymphatic delivery of tacrolimus. J Nanosci Nanotechnol. 15(2):1831–1841.
   PubMed Web of Science ®Google Scholar
• Chu Y, Qin C, Feng W, Sheriston C, Jane Khor Y, Medrano-Padial C, Watson BE, Chan T, Ling B, Stocks MJ, et al. 2021. Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes. Int J Pharm. 602:120621.
   PubMed Web of Science ®Google Scholar
• Conacher M, Alexander J, Brewer JM. 2001. Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine. 19(20–22):2965–2974.
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. 2005. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci. 24(4):381–388.
   PubMed Web of Science ®Google Scholar
• Dapergolas G, Gregoriadis G. 1976. Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. Lancet. 308(7990):824–827.
   Google Scholar
• Dhaval M, Vaghela P, Patel K, Sojitra K, Patel M, Patel S, Dudhat K, Shah S, Manek R, Parmar R. 2021. Lipid-based emulsion drug delivery systems – a comprehensive review. Drug Deliv Transl Res. https://pubmed.ncbi.nlm.nih.gov/34609731/
   PubMed Web of Science ®Google Scholar
• Dokania S, Joshi AK. 2015. Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead. Drug Deliv. 22(6):675–690.
   PubMed Web of Science ®Google Scholar
• Ehrhardt C, Kim K-J. 2007. Drug Absorption Studies: In Situ, In Vitro and In Silico Models. http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:No+Title#0%5Cnhttp://books.google.com/books?id=3geWUtmDPxwC&pgis=1.
   Google Scholar
• El-Laithy HM, Basalious EB, El-Hoseiny BM, Adel MM. 2015. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: simultaneous portal blood absorption and lymphatic delivery. Int J Pharm. 490(1–2):146–154.
   PubMed Web of Science ®Google Scholar
• Fang G, Tang B, Chao Y, Zhang Y, Xu H, Tang X. 2015. Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies. RSC Adv. 5(117):96437–96447.
   Web of Science ®Google Scholar
• Fanous MYZ, Phillips AJ, Windsor JA. 2007. Mesenteric lymph: the bridge to future management of critical illness. J Pancreas. 8:374–399.
   PubMedGoogle Scholar
• Feng W, Qin C, Cipolla E, Lee JB, Zgair A, Chu Y, Ortori CA, Stocks MJ, Constantinescu CS, Barrett DA, et al. 2021. Inclusion of medium-chain triglyceride in lipid-based formulation of cannabidiol facilitates micellar solubilization in vitro, but in vivo performance remains superior with pure sesame oil vehicle. Pharmaceutics. 13(9):1349.
   PubMed Web of Science ®Google Scholar
• Fischer M, Franzeck UK, Herrig I, Costanzo U, Wen S, Schiesser M, Hoffmann U, Bollinger A. 1996. Flow velocity of single lymphatic capillaries in human skin. Am J Physiol. 270(1 Pt 2):H358–H363.
   PubMed Web of Science ®Google Scholar
• Foxwell AR, Cripps AW, Kyd JM. 2007. Optimization of oral immunization through receptor-mediated targeting of M cells. Hum Vaccin. 3(5):220–223.
   PubMed Web of Science ®Google Scholar
• Gershkovich P, Hoffman A. 2005. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability. Eur J Pharm Sci. 26(5):394–404.
   PubMed Web of Science ®Google Scholar
• Gibaud S, Attivi D. 2012. Microemulsions for oral administration and their therapeutic applications. Expert Opin Drug Deliv. 9(8):937–951.
   PubMed Web of Science ®Google Scholar
• Griffin BT, O'Driscoll CM. 2006. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J Pharm Pharmacol. 58(7):917–925.
   PubMed Web of Science ®Google Scholar
• Guan P, Lu Y, Qi J, Niu M, Lian R, Hu F, Wu W. 2011. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomedicine. 6:965–974.
   PubMed Web of Science ®Google Scholar
• Gupta VD. 1984. Stability of cefotaxime sodium as determined by high-performance liquid chromatography. J Pharm Sci. 73:565–567.
   PubMed Web of Science ®Google Scholar
• Gurumukhi VC, Sanjaykumar Bari B. 2021. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies. Drug Deliv Transl Res. https://pubmed.ncbi.nlm.nih.gov/34110597/
   Web of Science ®Google Scholar
• Guy-Grand D, Vassalli P. 1993. Gut intraepithelial T lymphocytes. Curr Opin Immunol. 5(2):247–252.
   PubMed Web of Science ®Google Scholar
• Han L, Yang Q, Shen T, Qing J, Wang J. 2016. Lymphatic transport of orally administered probucol-loaded mPEG-DSPE micelles. Drug Deliv. 23(6):1955–1961.
   PubMed Web of Science ®Google Scholar
• Han S, Hu L, Gracia Quach T, Simpson JS, Edwards GA, Trevaskis NL, Porter CJH. 2016. Lymphatic transport and lymphocyte targeting of a triglyceride mimetic prodrug is enhanced in a large animal model: studies in greyhound dogs. Mol Pharm. 13(10):3351–3361.
   PubMed Web of Science ®Google Scholar
• Han S. f, Yao T. t, Zhang X. x, Gan L, Zhu C, Yu H. z, Gan Y. 2009. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation. Int J Pharm. 379(1):18–24.
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Kawada J. 1979. Effects of oral administration of positively charged insulin liposomes on alloxan diabetic rats: preliminary study. Endocrinol Jpn. 26(3):337–344.
   PubMedGoogle Scholar
• Hayashi H, Fujimoto K, Cardelli JA, Nutting DF, Bergstedt S, Tso P. 1990. Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol – Gastrointest Liver Physiol. 259(5):G709–G719.
   Web of Science ®Google Scholar
• He H, Wang L, Ma Y, Yang Y, Lv Y, Zhang Z, Qi J, Dong X, Zhao W, Lu Y, et al. 2020. The biological fate of orally administered mPEG-PDLLA polymeric micelles. J Control Release. 327:725–736.
   PubMed Web of Science ®Google Scholar
• He H, Xie Y, Lv Y, Qi J, Dong X, Zhao W, Wu W, Lu Y. 2018. Bioimaging of intact polycaprolactone nanoparticles using aggregation-caused quenching probes: size-dependent translocation via oral delivery. Adv Healthcare Mater. 7(22):1800711.
   Web of Science ®Google Scholar
• Holm R, Müllertz A, Christensen E, Høy CE, Kristensen HG. 2001. Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats. Eur J Pharm Sci. 14(4):331–337.
   PubMed Web of Science ®Google Scholar
• Holm R, Porter CJH, Edwards GA, Müllertz A, Kristensen HG, Charman WN. 2003. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci. 20(1):91–97.
   PubMed Web of Science ®Google Scholar
• Holmberg I, Aksnes L, Berlin T, Lindbäck B, Zemgals J, Lindeke B. 1990. Absorption of a pharmacological dose of vitamin D3 from two different lipid vehicles in man: comparison of peanut oil and a medium chain triglyceride. Biopharm Drug Dispos. 11(9):807–815.
   PubMed Web of Science ®Google Scholar
• Hu X, Fan W, Yu Z, Lu Y, Qi J, Zhang J, Dong X, Zhao W, Wu W. 2016. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. Nanoscale. 8(13):7024–7035.
   PubMed Web of Science ®Google Scholar
• Imada C, Takahashi T, Kuramoto M, Masuda K, Ogawara KI, Sato A, Wataya Y, Kim HS, Higaki K. 2015. Improvement of oral bioavailability of n-251, a novel antimalarial drug, by increasing lymphatic transport with long-chain fatty acid-based self-nanoemulsifying drug delivery system. Pharm Res. 32(8):2595–2608.
   PubMed Web of Science ®Google Scholar
• Iwanaga K, Ono S, Narioka K, Morimoto K, Kakemi M, Yamashita S, Nango M, Oku N. 1997. Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract. Int J Pharm. 157(1):73–80.
   Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. 1989. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol. 41(12):809–812.
   PubMed Web of Science ®Google Scholar
• Japan Oil Chemists' Society. 1990. The handbook of oil chemistry. Third ed., Tokyo: Maruzen Co. Ltd., p. 104–112.
   Google Scholar
• Jeong SH, Jang JH, Lee YB. 2021. Oral delivery of topotecan in polymeric nanoparticles: lymphatic distribution and pharmacokinetics. J Control Release. 335:86–102.
   PubMed Web of Science ®Google Scholar
• Johnston A, Gudjonsson JE, Sigmundsdottir H, Runar Ludviksson B, Valdimarsson H. 2005. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin Immunol. 114(2):154–163.
   PubMed Web of Science ®Google Scholar
• Kandikattu HK, Mishra A. 2018. Immunomodulatory effects of tacrolimus (FK506) for the treatment of allergic diseases. Int J Cell Biol Physiol. 1(1–2):5–13.
   PubMedGoogle Scholar
• Kaplan J, Mcpherson JM. 2007. Methods of treating autoimmune diseases. WO 2007121233.
   Google Scholar
• Kay JE, Sampare-Kwateng E, Geraghty F, Morgan GY. 1991. Uptake of FK 506 by lymphocytes and erythrocytes. Transplant Proc. 23(6):2760–2762.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim Y, Lee J. 2013. Liposomal formulations for enhanced lymphatic drug delivery. Asian J Pharm Sci. 8(2):96–103.
   Google Scholar
• Koo SI, Noh SK. 2001. Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of alpha-tocopherol in adult rats. J Nutr. 131(3):717–722.
   PubMed Web of Science ®Google Scholar
• Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, Gonschior AK, Dralle H, Hackbarth I, Sewing KF. 1995. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos. 23(12):1315–1324.
   PubMed Web of Science ®Google Scholar
• Lawless E, Griffin BT, O'Mahony A, O'Driscoll CM. 2015. Exploring the impact of drug properties on the extent of intestinal lymphatic transport – in vitro and in vivo studies. Pharm Res. 32(5):1817–1829.
   PubMed Web of Science ®Google Scholar
• Lee G, Han S, Lu Z, Hong J, Phillips ARJ, Windsor JA, Porter CJH, Trevaskis NL. 2021. Intestinal delivery in a long-chain fatty acid formulation enables lymphatic transport and systemic exposure of orlistat. Int J Pharm. 596:120247.
   PubMed Web of Science ®Google Scholar
• Lefevre ME, Joel DD, Schidlovsky G. 1985. Retention of ingested latex particles in Peyer's patches of germfree and conventional mice. Proc Soc Exp Biol Med. 179(4):522–528.
   PubMed Web of Science ®Google Scholar
• LeFevre ME, Olivo R, Vanderhoff JW, Joel DD. 1978. Accumulation of Latex in Peyer's patches and its subsequent appearance in villi and mesenteric lymph nodes. Proc Soc Exp Biol Med. 159(2):298–302.
   PubMed Web of Science ®Google Scholar
• Lespine A, Chanoit G, Bousquet-Melou A, Lallemand E, Bassissi FM, Alvinerie M, Toutain PL. 2006. Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs. Eur J Pharm Sci. 27(1):37–43.
   PubMed Web of Science ®Google Scholar
• Li F, Hu R, Wang B, Gui Y, Cheng G, Gao S, Ye L, Tang J. 2017. Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake. Acta Pharm Sin B. 7(3):353–360.
   PubMed Web of Science ®Google Scholar
• Ling SS, Magosso E, Khan NA, Yuen KH, Barker SA. 2006. Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm. 32(3):335–345.
   PubMed Web of Science ®Google Scholar
• Livesey G. 2000. The absorption of stearic acid from triacylglycerols: an inquiry and analysis. Nutr Res Rev. 13(2):185–214.
   PubMed Web of Science ®Google Scholar
• Maji I, Mahajan S, Sriram A, Medtiya P, Vasave R, Khatri DK, Kumar R, Singh SB, Madan J, Singh PK. 2021. Solid self emulsifying drug delivery system: superior mode for oral delivery of hydrophobic cargos. J Control Release. 337:646–660.
   PubMed Web of Science ®Google Scholar
• Managuli RS, Raut SY, Reddy MS, Mutalik S. 2018. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs. Expert Opin Drug Deliv. 15(8):787–804.
   PubMed Web of Science ®Google Scholar
• McDonald GB, Saunders DR, Weidman M, Fisher L. 1980. Portal venous transport of long-chain fatty acids absorbed from rat intestine. Am J Physiol. 239(3):G141–G150.
   PubMed Web of Science ®Google Scholar
• Mistry Rajan B, Sheth NS. 2011. A review: self emulsifying drug delivery system. Int J Pharm Pharm Sci. 3(Suppl. 2):23–28.
   Google Scholar
• Müller RH, Radtke M, Wissing SA. 2002. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 242(1–2):121–128.
   PubMed Web of Science ®Google Scholar
• Müller RH, Runge S, Ravelli V, Mehnert W, Thünemann AF, Souto EB. 2006. Oral bioavailability of cyclosporine: Solid Lipid Nanoparticles (SLN) versus drug nanocrystals. Int J Pharm. 317(1):82–89.
   PubMed Web of Science ®Google Scholar
• Nankervis R, Davis SS, Day NH, Shaw PN. 1996. Intestinal lymphatic transport of three retinoids in the rat after oral administration: effect of lipophilicity and lipid vehicle. Int J Pharm. 130(1):57–64.
   Web of Science ®Google Scholar
• Olbrich C, Kayser O, Müller Rainer H. 2002a. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN) – effect of surfactants, storage time and crystallinity. Int J Pharm. 237(1–2):119–128.
   PubMed Web of Science ®Google Scholar
• Olbrich C, Kayser O, Müller Rainer H. 2002b. Enzymatic degradation of Dynasan 114 SLN – effect of surfactants and particle size. J Nanoparticle Res. 4(1/2):121–129.
   Web of Science ®Google Scholar
• Ms P, Naha A, Shetty D, Nayak UY. 2020. Lymphatic drug transport and associated drug delivery technologies: a comprehensive review. Curr Pharm Des. 26.
   Google Scholar
• Palin KJ, Wilson CG, Davis SS, Phillips AJ. 1982. The effect of oils on the lymphatic absorption of DDT. J Pharm Pharmacol. 34(11):707–710.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Paliwal SR, Mishra N, Mehta A, Vyas SP. 2009. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm. 380(1–2):181–188.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP. 2009. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine. 5(2):184–191.
   PubMed Web of Science ®Google Scholar
• Patel HM, Ryman BE. 1976. Oral administration of insulin by encapsulation within liposomes. FEBS Lett. 62(1):60–63.
   PubMed Web of Science ®Google Scholar
• Patel P, Patel M. 2021. Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: in vitro, cell line and in vivo evaluation. Eur J Pharm Sci. 159:105715.
   PubMed Web of Science ®Google Scholar
• Porter CJH, Charman WN. 2001. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 50(1–2):61–80.
   PubMed Web of Science ®Google Scholar
• Qin C, Chu YJu, Feng W, Fromont C, He S, Ali J, Lee JB, Zgair A, Berton M, Bettonte S, et al. 2021. Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach. J Control Release. 329:1077–1089.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Hussain A, Hussain MS, Mirza MA, Iqbal Z. 2013. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm. 39(1):1–19.
   PubMed Web of Science ®Google Scholar
• Rangaraj N, Pailla SR, Shah S, Prajapati S, Sampathi S. 2020. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach. Drug Deliv Transl Res. 10(5):1476–1494.
   PubMed Web of Science ®Google Scholar
• Rieux AD, Fievez V, Garinot M, Schneider YJ, Préat V. 2006. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 116(1):1–27.
   PubMed Web of Science ®Google Scholar
• Ryšánek P, Grus T, Šíma M, Slanař O. 2020. Lymphatic transport of drugs after intestinal absorption: impact of drug formulation and physicochemical properties. Pharm Res. 37(9):166.
   PubMed Web of Science ®Google Scholar
• Shackleford DM, Faassen WA, Houwing N, Lass H, Edwards GA, Porter CJH, Charman WN. 2003. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J Pharmacol Exp Ther. 306(3):925–933.
   PubMed Web of Science ®Google Scholar
• Shete H, Chatterjee S, De A, Patravale V. 2013. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies. Int J Pharm. 454(1):584–592.
   PubMed Web of Science ®Google Scholar
• Shukla A, Khatri K, Gupta PN, Goyal AK, Mehta A, Vyas SP. 2008. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci. 11(1):59–66.
   PubMed Web of Science ®Google Scholar
• Subramaniam B, Siddik ZH, Nagoor NH. 2020. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J Nanoparticle Res. 22:141.
   Web of Science ®Google Scholar
• Sun M, Zhai X, Xue K, Hu L, Yang X, Li G, Si L. 2011. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci. 43(3):132–140.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. 1996. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res. 13(6):896–901.
   PubMed Web of Science ®Google Scholar
• Thomas SN, Schudel A. 2015. Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery. Curr Opin Chem Eng. 7:65–74.
   PubMed Web of Science ®Google Scholar
• Tong Y, Zhang Q, Shi W, Wang J. 2019. Mechanisms of oral absorption improvement for insoluble drugs by the combination of phospholipid complex and SNEDDS. Drug Deliv. 26(1):1155–1166.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Caliph SM, Nguyen G, Tso P, Charman WN, Porter CJH. 2013. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport. Pharm Res. 30(12):3254–3270.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter CJH. 2008. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev. 60(6):702–716.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter CJH. 2010a. Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation? Mol Pharm. 7(6):2297–2309.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Kaminskas LM, Porter CJH. 2015. From sewer to saviour – targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov. 14(11):781–803.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Porter CJH, Charman WN. 2006. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport. J Pharmacol Exp Ther. 316(2):881–891.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Shanker RM, Charman WN, Porter CJH. 2010b. The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles. Pharm Res. 27(9):1949–1964.
   PubMed Web of Science ®Google Scholar
• Vahouny GV, Treadwell CR. 1959. Comparative effects of dietary fatty acids and triglycerides on lymph lipids in the rat. Am J Physiol. 196(4):881–883.
   PubMed Web of Science ®Google Scholar
• Valicherla GR, Dave KM, Syed AA, Riyazuddin M, Gupta AP, Singh A, Wahajuddin Mitra K, Datta D, Gayen JR. 2016. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Sci Rep. 6(1):1–11.
   PubMed Web of Science ®Google Scholar
• Wadhwa J, Nair A, Kumria R. 2012. Emulsion forming drug delivery system for lipophilic drugs. Acta Pol Pharm – Drug Res. 69(2):179–191.
   PubMed Web of Science ®Google Scholar
• Walmsley S, Avihingsanon A, Slim J, Ward DJ, Ruxrungtham K, Brunetta J, Bredeek UF, Jayaweera D, Guittari CJ, Larson P, et al. 2009. Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-I therapy in adults. J Acquir Immune Defic Syndr. 50(4):367–374.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma W, Tu P. 2015. The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: in vitro and in vivo. Colloids Surf B Biointerfaces. 133:108–119.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang C, Han N, Luo J, Zhang S, Wang C, Jia Z, Du S. 2021. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism. Drug Deliv. 28(1):1664–1672.
   PubMed Web of Science ®Google Scholar
• Wang Y, Oliver G. 2010. Current views on the function of the lymphatic vasculature in health and disease. Genes Dev. 24(19):2115–2126.
   PubMed Web of Science ®Google Scholar
• White KL, Nguyen G, Charman WN, Edwards GA, Faassen WA, Porter CJH. 2009. Lymphatic transport of methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU. J Pharmacol Exp Ther. 331(2):700–709.
   PubMed Web of Science ®Google Scholar
• White WAO, Zhou Y, Crane A, Dixon P, Quadt F, Flendrig LM. 2017. Modeling the dose effects of soybean oil in salad dressing on carotenoid and fat-soluble vitamin bioavailability in salad vegetables. Am J Clin Nutr. 106(4):1041–1051.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou A, Lu C, Wang L. 2011. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems. Eur J Pharm Sci. 42(4):348–353.
   PubMed Web of Science ®Google Scholar
• Xia F, Chen Z, Zhu Q, Qi J, Dong X, Zhao W, Wu W, Lu Y. 2021. Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route. Acta Pharm Sin B. 11(4):1010–1020.
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhou A, Wu H, Bi Y. 2019. Development and in vivo evaluation of baicalin-loaded W/O nanoemulsion for lymphatic absorption. Pharm Dev Technol. 24(9):1155–1163.
   PubMed Web of Science ®Google Scholar
• Yáñez JA, Wang SWJ, Knemeyer IW, Wirth MA, Alton KB. 2011. Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev. 63(10–11):923–942.
   PubMed Web of Science ®Google Scholar
• Ye J, Gao Y, Ji M, Yang Y, Wang Z, Wang B, Jin J, Li L, Wang H, Xu X, et al. 2021. Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity. J Immunother Cancer. 9(7):e002753.
   PubMed Web of Science ®Google Scholar
• Ye J-Y, Chen Z-Y, Huang C-L, Huang B, Zheng Y-R, Zhang Y-F, Lu B-Y, He L, Liu C-S, Long X-Y. 2020. A non-lipolysis nanoemulsion improved oral bioavailability by reducing the first-pass metabolism of raloxifene, and related absorption mechanisms being studied. IJN. 15:6503–6518.
   Web of Science ®Google Scholar
• Ye Y, Zhang T, Li W, Sun H, Lu D, Wu B, Zhang X. 2016. Glucose-based mesoporous carbon nanospheres as functional carriers for oral delivery of amphiphobic raloxifene: insights into the bioavailability enhancement and lymphatic transport. Pharm Res. 33(3):792–803.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Nakanishi K, Yoshioka T, Tsutsui Y, Maeda A, Kondo H, Sako K. 2016. Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 production . Eur J Pharm Biopharm. 100:58–65.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Sako K, Kondo H. 2020. Design of novel tacrolimus formulations with chemically synthesized oils for oral lymphatic delivery. Drug Dev Ind Pharm. 46(2):219–226.
   PubMed Web of Science ®Google Scholar
• Zhang B, Xue A, Zhang C, Yu J, Chen W, Sun D. 2016. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel. Pharmazie. 71(6):320–326.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X. 2006. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm. 327(1–2):153–159.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lu Y, Qi J, Wu W. 2021. An update on oral drug delivery via intestinal lymphatic transport. Acta Pharm Sin B. 11(8):2449–2468.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qi J, Lu Y, Wu W, Yuan H. 2021. Peroral targeting of drug micro or nanocarriers to sites beyond the gastrointestinal tract. Med Res Rev. 41(4):2590–2598.
   PubMed Web of Science ®Google Scholar
• Zhou A, Lu T, Wang L, Lu C, Wang L, Wan M, Wu H. 2014. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. Pharm Dev Technol. 19(6):743–747.
   PubMed Web of Science ®Google Scholar